OGMYX
Price
$67.68
Change
+$0.33 (+0.49%)
Updated
Sep 11 closing price
Net Assets
4.21B
RYPMX
Price
$314.40
Change
+$1.58 (+0.51%)
Updated
Sep 11 closing price
Net Assets
135.02M
Interact to see
Advertisement

OGMYX vs RYPMX

OGMYX vs RYPMX Comparison Chart in %
View a ticker or compare two or three
VS
OGMYX vs. RYPMX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGMYX is a Hold and RYPMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OGMYX has more cash in the bank: 4.21B vs. RYPMX (135M). RYPMX pays higher dividends than OGMYX: RYPMX (2.55) vs OGMYX (0.50). OGMYX was incepted earlier than RYPMX: OGMYX (16 years) vs RYPMX (33 years). RYPMX (1.33) is less costly to investors than OGMYX (0.81). RYPMX is a more actively managed with annual turnover of: 328.00 vs. OGMYX (74.00). OGMYX has a lower initial minimum investment than RYPMX: OGMYX (1000) vs RYPMX (2500). RYPMX annual gain was more profitable for investors over the last year : 43.35 vs. OGMYX (38.52). OGMYX return over 5 years is better than : 191.89 vs. RYPMX (172.64).
OGMYXRYPMXOGMYX / RYPMX
Total Expense Ratio0.811.2863%
Annual Report Gross Expense Ratio0.811.3361%
Fund Existence16 years33 years-
Gain YTD13.78614.86093%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.21B135M3,119%
Annual Yield % from dividends0.502.5520%
Returns for 1 year38.5243.3589%
Returns for 3 years217.36234.7393%
Returns for 5 years191.89172.64111%
Returns for 10 years307.49225.16137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ELGAX6.090.06
+1.00%
Columbia Select Large Cap Growth A
GTDYX49.91N/A
N/A
Invesco Emerging Markets ex-China Y
VFWSX166.45N/A
N/A
Vanguard FTSE All-Wld ex-US Idx Instl
FIJDX67.08N/A
N/A
Fidelity Advisor Gold Z
BIPIX93.86N/A
N/A
ProFunds Biotechnology UltraSector Inv